Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

By sjmartinez • May 14, 2024

Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a). Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. PMID: 38741703; PMCID: PMC11090055.

Tags: Aspirin, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipoprotein(a), NHANES, Publications

Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study

Luchsinger JA, Pan Q, Knowler WC, Munshi M, Watson K, Gadde KM, Schlögl M, Carmichael OT; DPP Research Group. Association of BMI and Cognitive Performance[...]

A Case of Premature Ventricular Contraction-Induced Cardiomyopathy

Mazar M, Hingorany S. A Case of Premature Ventricular Contraction-Induced Cardiomyopathy. Cureus. 2025 Aug 26;17(8):e91034. doi: 10.7759/cureus.91034. PMID: 41018405; PMCID: PMC12462810.

Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials

Ahmed M, Hashmi TM, Shafiq A, Ashraf H, Jain H, Khanji MY, Providência R, Chahal AA, Rana JS, Farhan M, Ahmed R, Fudim M, Fonarow[...]